¹⁸F-FDG PET/CT versus bone scintigraphy in the follow-up of gastric cancer

详细信息    查看全文

• 作者：M. Sollini^a ; ^{martinasollini@msn.com" class="auth_mail" title="E-mail the corresponding author} ; ^{martina.sollini@multimedica.it" class="auth_mail" title="E-mail the corresponding author} ; L. Calabrese^a ; B. Zangheri^a ; P.A. Erba^b ; A. Gramaglia^c ; M. Gasparini^a
• 关键词：Gastric cancer ; 2-Deoxy-2-(18F)fluoro-d-glucose positron emission tomography/computed tomography ; Bone scintigraphy
• 刊名：Revista Española de Medicina Nuclear e Imagen Molecular
• 出版年：2016
• 出版时间：March-April 2016
• 年：2016
• 卷：35
• 期：2
• 页码：121-123
• 全文大小：627 K

文摘

A 53-year-old patient underwent a positron emission tomography/computed tomography with 2-fluoro-2-deoxy-d-glucose (¹⁸F-FDG PET/CT) in the suspicious of gastric tumor recurrence (mediastinal and abdominal lymph nodes). PET/CT identified only an area of ¹⁸F-FDGuptake in the twelfth thoracic vertebrae. Unexpectedly, a bone scintigraphy revealed many “hot” spots changing the diagnosis (single metastasis versus plurimetastatic disease) and impacting on patient's management.